Intraoperative Assessment of Portal Vein Arterialization: A Review of Heterogeneous Practices and Proposal for Standardized Flow Evaluation - Federico Lozio
Artificial intelligence-assisted intraoperative navigation for safe right liver mobilization in pure laparoscopic donor hepatectomy: an experimental multi-institutional validation study - Inho Lee
Robotic Liver Transplantation: University of Modena experience- Paolo Magistri
Circulating Tumor DNA in Liver Transplantation for Unresectable Colorectal Liver Metastasis - Abigail Loszko
R0N0 resection for perihilar cholangiocarcinoma offers survival similar to transplantation: A multicentre pan-European study - Aarathi Vijayashanker
Results of the Initial Cases from the International Ex Situ Liver Surgery Database - Alejandro Serrablo
ALPPS for CRLM: risk analysis for early recurrence - Jun Li
Evolving Patterns of Adjuvant Chemotherapy And Survival After Surgery For Peri-hilar Cholangiocarcinoma: Results From The UK Nationwide Capbil Study - Aarathi Vijayashanker
Prognosis of associating liver partition and portal vein ligation for staged hepatectomy to treat patients with hepatocellular carcinoma -Yiming Zhao
A Novel Bioengineered Pancreatojejunostomy to Prevent Postoperative Fistula: Ex Vivo and In Vivo Evaluation of the PJ-Ring Device - Graziano Oldani
Surgical Strategies: Resection as a Viable DS strategy in giant and multifocal HCC (Intermediate Stage) - Dong-Sik Kim
The Transplantation Paradigm: Where do we draw the line? Expanding Role and Considerations - Christian Toso
Optimizing Treatment Pathways: Neoadjuvant Approaches in Intermediate Stage HCC: upfront vs LRT vs systemic vs combo approaches - Should u do systemic as neoadjuvant and then surgery - Umut Demirci
State of the Art Lecture I: LT for HCC - Where are we in 2025? And what the future holds.
Speaker: Karim Halazun
Q&A Session moderated by Gonzalo Sapisochin & Myron Schwartz
Moderators: Elvan Onur Kirimker & Blayne Amir Sayed
Novel Approach to Viability Assessment of Split Liver Grafts Using Hypothermic Oxygenated Perfusion - Geofia Crasta
Promoting Microsurgical Competence in arterial reconstruction for Living-Donor Liver Transplantation: A Hands-On Training Model by the ISEM Japan Chapter - Shintaro Yagi
Parenchymal-Sparing One-Stage Hepatectomy Matches Liver Transplantation Survival In Bilobar Colorectal Liver Metastases: Toward A Refinement Of Transplant Candidacy - Flavio Milana
Liver Transplantation Using Split Or Reduced Liver Grafts – Czech Experience With 289 Consecutive Cases - Marek Kysela
Impact of Intravenous Somatostatin on LDLT Right Lobe Donor Outcomes -Emre Aray
Total Robotic Liver Transplant: Early Experience and Short-term Outcomes - Diego Chaparro Zaraza
A Randomized Controlled Trial Of Resection Versus Thermal Ablation Of Colorectal Cancer Liver Metastases (New Comet) - Ingrid Schrøder Hansen
Graft-to-Recipient Weight Ratio, Graft Inflow Modulation, and Small-for-Size Syndrome: Insights from the International Living Donor Liver Transplant Registry (LDLTregistry.org) -Dieter Broering
Liver Defatting Using Rapamycin and Normothermic Ex-situ Perfusion: The RAPAPERF Trial - Célia Turco
1,000 Robotic Operations: Establishing Standards for the Safe Integration of Robotic Innovation in Transplant Surgery - Diego Chaparro Zaraza
State of the Art Lecture II: Extreme Liver Surgery; where are we in 2025
Speaker: Daniel Azoulay
Q&A Session moderated by Deniz Balci & Gonzalo Sapisochin
Moderators: Concepción Gómez-Gavara & Fernando Rotellar
Robotic Liver Resection With Versus Without Common Bile Duct Resection For Gallbladder Cancer: A Multicentric International Propensity Score-Matched Comparative Analysis - Giuseppe Esposito
Improved Short-Term Outcomes with Fully Robotic Recipient Adult Living Donor Liver Transplantation: A Comparative Study -Dieter Broering
Machine Learning-Based risk assessment for Postoperative Bile Leakage After Liver Resection - Simone Conci
AI-Driven Markerless Augmented Reality Navigation for Enhanced Spatial Recognition in Liver Surgery - Maki Sugimoto
Outcomes Of Robotic Versus Open Liver Resection With Common Bile Duct Resection For Gallbladder Cancer: An International Multi-Institutional Propensity Score-Matched Study -Giuseppe Esposito
Predicting The Best Potential Treatment By Artificial Intelligence For Patients Affected By Hepatocellular Carcinoma: Development Of A Tailored Model On Real-World Big Data - Simone Famularo
Intracardiac Thrombosis and Its Management During Liver Transplantation: International, Multi-Center, Case-Control Study - Luca del Prete
Neoadjuvant Treatment Followed by Surgery Versus Upfront Surgery for Intrahepatic Cholangiocarcinoma: An International Multicenter Cohort Study - Anudari Zorigtbaatar
Ten-year experience review - pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability -Yi Pang Brian Liu
Liver Resection For Ovarian Cancer Liver Metastases: Survival Comparison Between Liver Peritoneal Implants Versus Intrahepatic Metastases - Simone Famularo
Welcome and Introductory Remarks by Gonzalo Sapisochin, Nazia Selzner & Cythina Tsien
Joint ISLS & DEI in Transplant Session: Enabling Exemplary Care Through Behavioural Empathy
Speaker: Nouman Ashraf
Time Zone: (UTC-05:00) Eastern Time (US & Canada) [Change Time Zone]
Subject to change without notice.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MCI Group Canada. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Professions in scope for this activity are listed below.
Physicians
Amedco LLC designates this live activity for a maximum of 21.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
